Other content in this Stream
Introducing: Transparency Management with TrialScope
2 Steps for Correcting Non-compliance with EU Disclosure Regulations
On the EU CTR registry, many clinical trial results unavailable, and it appears many studies were registered but never updated. Here's a two-step process on how to correct this non-compliance.
Tackling the EU CTR Compliance Challenge
Survey Reveals Plain-Language Commitments Still Evolving
Results of a recent TrialScope survey reveal that most sponsors are committing to providing plain-language summaries for Phase 2 – 4 clinical trials, with some extending to Phase 1 studies.
3 Immediate Actions for Disclosure Compliance
Introduction to Clinical Trial Disclosure
How Do Leading Organizations Approach Disclosure?
Prepared for the Global Demand for Data Transparency?
Quick Wins You Can Expect as a TrialScope Customer
The Final Rule: Challenges and Best Practices
What Are the Penalties of Disclosure Non-Compliance?
One Source Drives One Process for Clinical Trial Transparency
Why Should Smaller Pharma Companies Care About Disclosure?
Why Trial Sponsors Fail to Comply with Global Transparency Requirements
Improving Compliance While Reducing Resources
An Innovative Approach to Trial Results Summaries
Clinical Trial Transparency - The Technology Imperative
Five Reasons You May Look Non Compliant and What You Can Do About It
Risk-Based Validation of SaaS Solutions
Clinical Trial Disclosure: The Technology Imperative